Studies	O
of	O
the	O
carcinogenicity	O
of	O
caffeic	MEDICINE
acid	MEDICINE
have	O
mixed	O
results	O
.	O
Some	O
studies	O
have	O
shown	O
that	O
it	O
inhibits	O
carcinogenesis	O
,	O
and	O
other	O
experiments	O
show	O
carcinogenic	O
effects	O
.	O
Oral	O
administration	O
of	O
high	O
doses	O
of	O
caffeic	MEDICINE
acid	MEDICINE
inrats	O
has	O
caused	O
stomach	O
papillomas	O
.	O
In	O
the	O
same	O
study	O
,	O
high	O
doses	O
of	O
combined	O
antioxidants	O
,	O
including	O
caffeic	MEDICINE
acid	MEDICINE
,	O
showed	O
a	O
significant	O
decrease	O
in	O
growth	O
of	O
colon	O
tumors	O
in	O
those	O
same	O
rats	O
.	O
No	O
significant	O
effect	O
was	O
noted	O
otherwise	O
.	O
Caffeic	MEDICINE
acid	MEDICINE
is	O
listed	O
under	O
some	O
Hazard	O
Data	O
sheets	O
as	O
a	O
potential	O
carcinogen	O
,	O
as	O
has	O
been	O
listed	O
by	O
the	O
International	ORGANIZATION
Agency	ORGANIZATION
for	ORGANIZATION
Research	ORGANIZATION
on	O
Cancer	O
as	O
a	O
Group	O
2B	O
carcinogen	O
-LRB-	O
`	O
possibly	O
carcinogenic	O
to	O
humans	O
'	O
-RRB-	O
.	O
More	O
recent	O
data	O
show	O
that	O
bacteria	O
in	O
the	O
rats	O
'	O
guts	O
may	O
alter	O
the	O
formation	O
of	O
metabolites	O
of	O
caffeic	MEDICINE
acid	MEDICINE
.	O
Other	O
than	O
caffeic	MEDICINE
acid	MEDICINE
being	O
a	O
thiamine	O
antagonist	O
,	O
there	O
have	O
been	O
no	O
known	O
ill	O
effects	O
of	O
caffeic	MEDICINE
acid	MEDICINE
in	O
humans	O
.	O
